Journal of Pharmacy and Pharmacology · 2006 · 17 citations · 16 references
PharmacyNutritional SciencesPharmacologyBioavailabilityDrug DeliveryOral Drug DeliveryGastrointestinal AbsorptionGastrointestinal PharmacologyGastrointestinal TransitIntestinal AbsorptionOral Bioavailability EnhancementExcipients EffectsGamma Camera ImagingIntestinal Absorption EnhancementIntestinal BioavailabilityIntestinal Transit TimeSmall Intestinal TransitSolubilizing ExcipientsTechnetium-99m Labeling
The accelerating effect of polyethylene glycol 400 on small intestinal transit has been previously reported. The aim of this study was to investigate the influence of other solubility-enhancing excipient, propylene glycol, D-alpha-tocopheryl-polyethylene glycol-1,000 succinate (VitE-TPGS) and Capmul MCM, on human intestinal transit. A 5-g dose of each excipient was administered to seven healthy male subjects. Propylene glycol and VitE-TPGS were administered dissolved in 150 mL water. Capmul MCM was administered in the form of four 000 hard gelatin capsules to mask its taste and then given with 150 mL water. On a separate occasion, 150 mL water was administered as the control. Each formulation was radiolabelled with technetium-99 m to follow its transit using a gamma camera. The mean small intestinal transit times were 234, 207, 241 and 209 min for the control, propylene glycol, VitE-TPGS and Capmul MCM treatments, respectively. Although there were differences in the small intestinal transit times for the excipients investigated compared with the control, none of the results were statistically significant. Unlike polyethylene glycol 400 at the same dose of 5 g, the excipients tested (propylene glycol, VitE-TPGS and Capmul MCM) had little or no impact on small intestinal transit.
16
Transit of pharmaceutical dosage forms through the small intestine.
S.S. Davis, John G. Hardy, J W Fara · Gut · 1986 · 848 citations · Full text